Promising results for the treatment of diabetic foot ulcers using the Adtec SteriPlas

We are excited to show you a recent conference poster presented at the BSAC Spring 2019 conference, submitted by Kettering General Hospital NHS Foundation Trust.

The poster shows the promising results of the using the Adtec SteriPlas on diabetic foot ulcers that are stalled by biofilm. The SteriPlas “is postulated as an alternative for antibiotics for patients where antibiotic therapy is difficult (due to resistance or adverse effects) or as an adjunct treatment for patients with chronic wounds including those with biofilms”.

Contact us at to learn more about how the Adtec SteriPlas may benefit your non-healing wound patients.

Adtec Healthcare confirmed to exhibit at two conferences this year

Adtec Healthcare is excited to announce that we will be exhibiting at two conferences so far this year.

We will be exhibiting at The 136th Congress of the German Society of Surgery ( in Munich, Germany between the 26th-29th March 2019. Dr Heinrich Rotering will also be presenting “Infected Implant – Complex wound treatment: Cold atmospheric plasma and advanced NPWT” at this conference at 13:10 (GMT) on 29th March 2019. His presentation will feature our medical device, the Adtec SteriPlas. We will be located at booth no. 150 where we welcome you to visit us.

We will also be exhibiting at the European Wound Management Association (EWMA) conference in Gothenburg, Sweden ( between the 5th-7th June 2019. You can find us at booth B10:22 where we will have our Adtec SteriPlas medical device ready to give a live demonstration on its effectiveness and simplicity of use.

To arrange a meeting at either of these conferences, please contact us at

New Corporate Management Team at Adtec.

Adtec Europe is happy to announce a new President at our parent company Adtec Plasma Technology Co., Ltd Japan (listed on TSE 6668) - Mr Hidenori Morishita. Mr Morishita has been working at Adtec Japan for over 15 years primarily in the role of business development. 

Read more

Adtec Europe Ltd introduces new Actinic Keratoses Clinical Trial Results at the European Academy of Dermatology and Venerology Annual Meeting in Paris.

P0736 – Efficacy of cold atmospheric plasma versus diclofenac 3% gel in patients with actinic keratoses/field cancerization: preliminary results of a prospective, randomized, rater-blinded study (ACTICAP).

Read more

Leeds Teaching Hospitals NHS Trust joins as a trial centre for current RCT

Adtec Healthcare is excited to announce that Leeds Teaching Hospitals NHS Trust will be joining as a trial centre for our randomised controlled trial to evaluate the efficacy of non-thermal gas plasma on sub-clinical wound infection (biofilm) in patients with diabetic foot ulcers compared to those treated with standard care of dressings. The clinical team will be led by our clinical partners, Mr David Russell, the Podiatry and Vascular Research Teams in the Diabetes Limb Salvage Service at Leeds Teaching Hospitals. The Chief Investigator for the trial is Professor Steven Jeffery from HM Forces, Queen Elizabeth Hospital.

Read more

Adtec Healthcare to exhibit at EWMA

We are excited to be exhibiting at this year’s EWMA2018 in Krakow May 9th-11th. 

You can find us at booth number W114 where we will of course have our SteriPlas medical device on display, ready to give a live demonstration on how a quick 2-minute application is enough to deactivate microrganisms including antibiotic resistant bacteria. 

Read more

Innovation Award for SteriPlas Plasma Technology.

Adtec Healthcare congratulates Dr Rotering on his receipt of  the runner up Innovation award at the European Association for Cardio-Thoracic Surgery (EACTS) conference in Vienna on October 7th 2017..

Read more

Adtec receives second place award in the ‘Most Innovative Product’ Category in Journal of Wound Care awards

We are delighted to be awarded second place in the ‘Most Innovative Product:’ category at the Journal of Wound Care/ World Union of Wound Healing Societies awards. The results were announced at  the awards ceremony on Tuesday September 27th during the WUWHS congress in Florence.

Read more

Adtec Healthcare reports new case studies on the successful treatment of long-term chronic ulcers.

Adtec Healthcare reports the successful wound management of patients with long term chronic ulcers at 2 hospitals in Germany and Switzerland. Some of these results are included in case studies on the website. The patients had been suffering from long term chronic ulcers where all other treatments had failed. Treatment with Adtec SteriPlas gas plasma managed the infection and the ulcers progressed to complete healing. Following these encouraging case studies results, it is necessary to do a randomized controlled clinical trial to prove the clinical efficacy and benefits.

Read more

Clinical Trial to investigate the potential benefits of treating Actinic Keratosis with Adtec SteriPlas plasma technology.

Adtec Europe today announces the launch of a clinical trial to evaluate the change of the cutaneous microbiome in correlation to the efficacy of SteriPlas plasma technology compared to standard treatments on patients with Actinic Keratosis.

Read more